Atranorin significantly suppressed tumorigenic potential in a mose xenograft tumor model and reduced nuclear Ki-67 level which is a prototypic cell cycle related nuclear protein expressed in proliferating cells in all phase of the active cell cycle. Here, MKI67 is linked to neoplasm.